{"organizations": [], "uuid": "94176438d61a3e1ef1e60a6694cc7a938cb455cc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/09/globe-newswire-wolters-kluwer-health-completes-divestment-of-provation.html", "country": "US", "domain_rank": 767, "title": "Wolters Kluwer Health Completes Divestment of ProVation", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-09T21:31:00.000+02:00", "replies_count": 0, "uuid": "94176438d61a3e1ef1e60a6694cc7a938cb455cc"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/09/globe-newswire-wolters-kluwer-health-completes-divestment-of-provation.html", "ord_in_thread": 0, "title": "Wolters Kluwer Health Completes Divestment of ProVation", "locations": [], "entities": {"persons": [{"name": "wolters kluwer", "sentiment": "none"}, {"name": "alphen", "sentiment": "none"}, {"name": "rijn", "sentiment": "none"}], "locations": [{"name": "netherlands", "sentiment": "none"}], "organizations": [{"name": "wolters kluwer health", "sentiment": "negative"}, {"name": "wolters kluwer health completes divestment of provation wolters kluwer health", "sentiment": "negative"}, {"name": "kluwer wolters kluwer n.v.", "sentiment": "none"}, {"name": "clearlake capital group", "sentiment": "none"}, {"name": "wolters kluwer", "sentiment": "none"}, {"name": "euronext", "sentiment": "none"}, {"name": "euronext amsterdam", "sentiment": "none"}, {"name": "provation medical", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Wolters Kluwer Health Completes Divestment of ProVation\nMarch 9, 2018 - Wolters Kluwer Health announces today that it has completed the divestment of ProVation Medical to Clearlake Capital Group, L.P., as originally announced on January 11, 2018.\nAbout Wolters Kluwer\nWolters Kluwer N.V. (AEX: WKL) is a global leader in information, software solutions, and services for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.\nWolters Kluwer reported 2017 annual revenues of €4.4 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide.\nWolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).\nFor more information about our solutions and organization, visit www.wolterskluwer.com , follow us on Twitter , Facebook , LinkedIn , and YouTube .\nMedia\nAnnemarije Dérogée-Pikaar\nGlobal Brand & Communications\nt + 31 172 641 470\nannemarije.pikaar@wolterskluwer.com\nInvestors/Analysts\nMeg Geldens\nInvestor Relations\nt + 31 172 641 407\nir@wolterskluwer.com\nAnn Joyal\nGlobal Brand & Communications, Health\n781-392-3831\nann.joyal@wolterskluwer.com Forward-looking Statements\nThis report contains forward-looking statements. These statements may be identified by words such as \"expect\", \"should\", \"could\", \"shall\" and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.\nThis press release contains information which is to be made publicly available under Regulation (EU) 596/2014.\nAttachment:\nhttp://www.globenewswire.com/NewsRoom/AttachmentNg/971c65a3-e3bf-4318-8fbd-e5a8d1e4c466\nSource:Wolters Kluwer NV", "external_links": ["https://www.globenewswire.com/Tracker?data=LFbd-oTzWeRzsFkKXGM7JU8f4qRYI558aEnLq3CgjgzFwoQy6IYJkdmhfBgDfcbrEC287Ht9oloAAIjXoGXOh5vLe-3xxfC7LIE-3s8Qnv0=", "https://www.globenewswire.com/Tracker?data=InFRQkJdREGnCutvcem5gU8H93CAJztqjYXVxCBUjKOPme4sWBUvy0XVz-3GR4zYPgyrycABxD3TY5JkQV9BTE4HdujKgMWgy1JqYN0YNNs=", "https://www.globenewswire.com/Tracker?data=yeECHIaPMV3CMVcEmpiMuyvBw1bp0WiqiTbZioivCBCVKNUwKVAesmtRjrPpxuVnFmj8gvbs43G7y42BNca1pT2_SPZVUD62o09jUMmQL8vdlLBOaAN--eK0_2UWI7z8C09qTMtxWe44-1nFvkyDkfV53TUS0TPmLu34Bn_Q5bTKUtpsvZJ2jDlnrVmsEjIsp8pclTiNRskoPDeS-0XjZn0wzbOadoI8VWwFtFNC45ZmbjtMMaLBwvT-GrMG2OmIQ1VTgu8cuZITEEabNPKgzA==", "https://www.globenewswire.com/Tracker?data=U3vRejqwNcYsIv8BzntuI_skwRREdaLFS4uVnFNnDX_TXuIKV3l6Un3D4Iaz5DQz0kdqoCXJcrzMpaxA_TgrAC7DK1ggWIbm4AyF_i9tVfw=", "https://www.globenewswire.com/Tracker?data=P-0q9Cqx0ab5iUkV9u-jixDvs9sQPYQM-rLHMN2E4vp4ChFlx7EdvTxqywoJ8u7JPbdONDdYGwohyc4OLG2pZrEc0Pjoxc8w0cggS7tWmIuwoywmG0cAQhwxpSBNqsypK4cWetocp9VopbG0ilndpKWq45iz5OJY-MWKpR9lY5Cc5CcbaNIC0po8umSUX4PR", "https://www.globenewswire.com/Tracker?data=odj0q2ZKrE6mq37mO3ifWOsHQxPPCIEBpI5lk7UNpmICp50_Fe-mQmgr9CgPGG5728Hgt2fRmf2sTzF6teYCIg==", "http://www.globenewswire.com/NewsRoom/AttachmentNg/971c65a3-e3bf-4318-8fbd-e5a8d1e4c466", "https://www.globenewswire.com/Tracker?data=n6fgVn6nsCkhzH15S0VLFJJbS40lL3WrN--vqJAmNtEt-qfH2GuvWY_5cPTYlUYmaWq_siRkOHg7Uk0u7jaMqDpqwT0DgjnCA3OShm6SOMwaS129s2Jg-5tNgxwJklGgWUio6oi-OPWNkv7ORvL58-8mwz_JpyFFGXt-wMmDchf-cTsB9ACh9nS0vkD4WwyH1jCJg2QUC86ZqKTDbgr_aw=="], "published": "2018-03-09T21:31:00.000+02:00", "crawled": "2018-03-10T00:32:02.003+02:00", "highlightTitle": ""}